EPA Finalizes Much-Criticized “Transparency” Rule

The regulation, which requires that the agency give preference to dose-response studies in which the underlying data are available, could downplay findings key to defining the dangers of pollution.

Written byShawna Williams
| 3 min read
a sign reading "United States Environmental Protection Agency" on the side of a building

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, JIMFENG

Environmental Protection Agency head Andrew Wheeler announced a final rule today (January 5) that will impose new restrictions on how studies are weighed in formulating the agency’s regulations. While Wheeler and other proponents of the change say the rule ensures the public can access the data that undergird regulatory decisions, critics say it would shield polluters by limiting the consideration of studies that rely on confidential medical information. Such studies investigating the health effects of pollutants on human populations have formed the basis of major environmental regulations in the past.

“This really seems to be an attempt by Wheeler to permanently let major polluters trample on public health,” Benjamin Levitan, a senior attorney with the Environmental Defense Fund, tells the Associated Press. “It ties the hands of future administrations in how they can protect the public health.”

The change has been in the works since 2018, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies